SCHEMBL4653698

SCHEMBL4653698

O=C(/C=C/c1ccc(O)cc1O)/C=C/c1ccc(O)cc1O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 7/20 0.68
TYR P14679 3/20 0.68
MGAM O43451 1/20 0.62
GAA P10253 1/20 0.62
SI P14410 1/20 0.62
MGAM2 Q2M2H8 1/20 0.62
BACE1 P56817 1/20 0.62
JUN P05412 1/20 0.59
NFKB1 P19838 1/20 0.59
NFE2L2 Q16236 1/20 0.59
SYNJ2 O15056 1/20 0.55
TTR P02766 1/20 0.55
CYP1A1 P04798 1/20 0.55
BCHE P06276 1/20 0.55
MMP2 P08253 1/20 0.55
ALOX5 P09917 1/20 0.55
PTPN1 P18031 1/20 0.55
PTGS1 P23219 1/20 0.55
CYP1B1 Q16678 1/20 0.55
PTPN22 Q9Y2R2 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4653701 1.00 CHRNA7 (0.68) CHRNA7TYRMGAMGAASI
SCHEMBL89187 0.86 MIF (0.68) CHRNA7TYRMGAMGAASI
SCHEMBL28140874 0.86 MIF (0.68) CHRNA7TYRMGAMGAASI
SCHEMBL28391865 0.86 MIF (0.68) CHRNA7TYRMGAMGAASI
SCHEMBL471946 0.86 MIF (0.68) CHRNA7TYRMGAMGAASI
SCHEMBL23260932 0.84 MGAM (0.63) CHRNA7TYRMGAMGAASI
SCHEMBL676889 0.84 CHRNA7 (0.64) CHRNA7TYRBACE1SYNJ2TTR
SCHEMBL617300 0.84 CHRNA7 (0.64) CHRNA7TYRMGAMGAASI
SCHEMBL8965269 0.84 BACE1 (0.84) CHRNA7TYRBACE1
SCHEMBL617301 0.84 CHRNA7 (0.64) CHRNA7TYRMGAMGAASI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9364424-B2 Topical cosmetic skin lightening compositions and methods of use thereof STIEFEL LABORATORIES, INC. (US) 2016-06-14 US disclosed
US-20160074315-A1 TOPICAL COSMETIC SKIN LIGHTENING COMPOSITIONS AND METHODS OF USE THEREOF STIEFEL LABORATORIES, INC. 2016-03-17 US disclosed
EP-1602354-B1 Use of polyglutamic acid or its salts MEIJI SEIKA KAISHA (JP) 2008-11-05 EP disclosed
EP-1604647-B1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof CHISSO CORP (JP) 2008-05-07 EP disclosed
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair MEIJI SEIKA KAISHA, LTD. (JP) 2006-07-27 US disclosed
US-20060018867-A1 Cosmetic composition and production thereof ICHIMARU PHARCOS CO., LTD 2006-01-26 US disclosed
EP-1604647-A1 Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof Ichimaru Pharcos Co., Ltd. (JP) 2005-12-14 EP disclosed
EP-1602354-A1 HAIR TREATMENT COMPOSITION AND HAIR COSMETIC FOR DAMAGED HAIR Meiji Seika Kaisha, Ltd. (JP) 2005-12-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060165636-A1 Hair treatment composition and hair cosmetic for damaged hair CUTA, COL14A1, PRKDC CHRNA7 3178/4885TYR 46/4885MGAM 2516/4885
US-20060018867-A1 Cosmetic composition and production thereof CUTA, PARG, TYR CHRNA7 2225/4885TYR 3/4885MGAM 391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.